ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

130
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Refresh
02 Jul 2019 00:00

Asia HY Monthly - Vulnerability Of Asian Credit Market To External Shocks (2019) - Lucror Analytics

In this month’s “In-Focus” section, we discuss the vulnerability of Asian credits to external shocks, with the threat this year being the...

Logo
57 Views
Share
26 Jun 2019 00:00

Asia HY Trade Recommendations - June 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for June includes a summary of our recommendations, as well as our high-conviction ideas. We also...

Logo
60 Views
Share
04 Jun 2019 00:00

Asia HY Monthly - LARA And Credit Bias Study - Lucror Analytics

In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments over the past few years for companies under our coverage,...

Logo
63 Views
Share
30 May 2019 00:00

Lucror Analytics - Morning Views Asia - 30 May 2019

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
60 Views
Share
30 May 2019 00:00

Glenmark - Earnings Flash - FY 2018-19 Results - Lucror Analytics

Glenmark's Q4 and FY 2018-19 results were positive. The momentum in revenue growth was sustained in the final quarter (following a surprisingly...

Logo
65 Views
Share
x